跳至主要内容
临床试验/ISRCTN40940943
ISRCTN40940943已完成2 期

PROgesterone Therapy for Endometrial Cancer prevention in obese women: an interventional trial

ational Institute for Health Research0 个研究点目标入组 40 人开始时间: 2015年4月23日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Women seen in sleep apnoea clinic at Salford Royal Hospital
  • 2. BMI>40
  • 3. Informed consent
  • 4. Aged 18 years or over
  • 5. Not actively trying to lose weight
  • 6. Normal up to date smear
  • 7. Normal endometrial sampling at screening

排除标准

  • 1. Previous hysterectomy
  • 2. LNG-IUS or IUD in situ or in previous 6 months
  • 3. Pregnant or breast feeding, previous endometrial ablation
  • 4. Breast cancer
  • 5. Congenital/acquired uterine anomaly
  • 6. Pelvic inflammatory disease or genital actinomycosis
  • 7. Immunodeficiency
  • 8. Mirena IUS contraindicated
  • 9. Taking systemic progestagens
  • 10. Patient actively trying to lose weight (awaiting bariatric surgery)

研究者

发起方
ational Institute for Health Research

相似试验